Sichuan Kelun Pharmaceutical Co., Ltd. (SHE:002422)
35.45
+3.22 (9.99%)
Apr 1, 2025, 3:04 PM CST
SHE:002422 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Market Capitalization | 51,129 | 42,829 | 37,335 | 26,621 | 27,803 | 33,821 | Upgrade
|
Market Cap Growth | 19.26% | 14.71% | 40.25% | -4.25% | -17.79% | 13.75% | Upgrade
|
Enterprise Value | 53,437 | 47,019 | 45,807 | 36,189 | 38,841 | 43,029 | Upgrade
|
Last Close Price | 32.23 | 28.12 | 25.24 | 17.54 | 17.71 | 20.97 | Upgrade
|
PE Ratio | 17.03 | 17.44 | 21.89 | 24.15 | 33.52 | 36.06 | Upgrade
|
Forward PE | 16.89 | 21.36 | 21.81 | 18.84 | 13.32 | 19.10 | Upgrade
|
PS Ratio | 2.21 | 2.00 | 1.96 | 1.54 | 1.69 | 1.92 | Upgrade
|
PB Ratio | 2.27 | 1.86 | 2.21 | 1.88 | 1.99 | 2.43 | Upgrade
|
P/TBV Ratio | 2.40 | 2.34 | 2.59 | 2.10 | 2.25 | 2.80 | Upgrade
|
P/FCF Ratio | 21.20 | 12.00 | 16.74 | 14.34 | 28.13 | 38.19 | Upgrade
|
P/OCF Ratio | 11.68 | 8.03 | 11.94 | 9.35 | 12.53 | 15.26 | Upgrade
|
EV/Sales Ratio | 2.38 | 2.19 | 2.41 | 2.10 | 2.36 | 2.44 | Upgrade
|
EV/EBITDA Ratio | 9.64 | 10.26 | 13.41 | 13.45 | 16.35 | 15.56 | Upgrade
|
EV/EBIT Ratio | 12.44 | 13.80 | 20.27 | 24.39 | 31.82 | 25.39 | Upgrade
|
EV/FCF Ratio | 22.16 | 13.18 | 20.54 | 19.49 | 39.29 | 48.58 | Upgrade
|
Debt / Equity Ratio | 0.22 | 0.31 | 0.67 | 0.84 | 0.88 | 0.84 | Upgrade
|
Debt / EBITDA Ratio | 1.03 | 1.54 | 3.28 | 4.41 | 5.21 | 4.20 | Upgrade
|
Debt / FCF Ratio | 2.37 | 2.00 | 5.06 | 6.42 | 12.52 | 13.12 | Upgrade
|
Asset Turnover | 0.61 | 0.61 | 0.58 | 0.54 | 0.52 | 0.58 | Upgrade
|
Inventory Turnover | 3.41 | 2.92 | 2.76 | 2.34 | 2.30 | 2.22 | Upgrade
|
Quick Ratio | 1.35 | 1.32 | 1.04 | 0.74 | 0.86 | 0.68 | Upgrade
|
Current Ratio | 1.88 | 1.83 | 1.38 | 1.05 | 1.20 | 0.96 | Upgrade
|
Return on Equity (ROE) | 14.14% | 13.27% | 11.00% | 6.17% | 5.67% | 7.60% | Upgrade
|
Return on Assets (ROA) | 7.22% | 6.03% | 4.30% | 2.92% | 2.40% | 3.48% | Upgrade
|
Return on Capital (ROIC) | 8.66% | 7.30% | 5.21% | 3.54% | 2.94% | 4.27% | Upgrade
|
Return on Capital Employed (ROCE) | 15.20% | 12.90% | 10.20% | 8.20% | 6.20% | 10.20% | Upgrade
|
Earnings Yield | 5.80% | 5.73% | 4.57% | 4.14% | 2.98% | 2.77% | Upgrade
|
FCF Yield | 4.72% | 8.33% | 5.97% | 6.97% | 3.55% | 2.62% | Upgrade
|
Dividend Yield | 1.61% | 2.84% | 2.44% | 2.43% | 1.80% | 2.03% | Upgrade
|
Payout Ratio | 47.36% | 45.87% | 60.60% | 90.33% | 136.49% | 90.54% | Upgrade
|
Buyback Yield / Dilution | -2.14% | -4.17% | -4.91% | 1.15% | -0.06% | -0.15% | Upgrade
|
Total Shareholder Return | -0.53% | -1.32% | -2.47% | 3.58% | 1.75% | 1.87% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.